pepmg_

Study summary · research use only

Ghrelin directly regulates bone formation

Study · animal · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2005 · DOI 10.1359/JBMR.041237 · PMID 15824852

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

In this rat study, the authors examined ghrelin's role in bone metabolism in vitro and in vivo. They report that ghrelin and its receptor GHS-R1a were identified in osteoblasts by RT-PCR and immunohistochemistry, and that ghrelin increased osteoblast-like cell number and DNA synthesis in a dose-dependent manner, an action suppressed by the GHS-R1a antagonist [D-Lys(3)]-GHRP-6. Ghrelin also increased osteoblast differentiation markers (Runx2, collagen alpha1 type I, alkaline phosphatase, osteocalcin), alkaline phosphatase activity, and matrix calcium accumulation. In vivo, ghrelin increased bone mineral density in Sprague-Dawley rats and GH-deficient spontaneous dwarf rats. The authors conclude ghrelin directly stimulated bone formation.

Abstract

To clarify the role of ghrelin in bone metabolism, we examined the effect of ghrelin in vitro and in vivo. Ghrelin and its receptor, GHS-R1a, were identified in osteoblasts, and ghrelin promoted both proliferation and differentiation. Furthermore, ghrelin increased BMD in rats. Our results show that ghrelin directly affects bone formation. Ghrelin is a gut peptide involved in growth hormone (GH) secretion and energy homeostasis. Recently, it has been reported that the adipocyte-derived hormone leptin, which also regulates energy homeostasis and opposes ghrelin's actions in energy homeostasis, plays a significant role in bone metabolism. This evidence implies that ghrelin may modulate bone metabolism; however, it has not been clarified. To study the role of ghrelin in skeletal integrity, we examined its effects on bone metabolism both in vitro and in vivo. We measured the expression of ghrelin and growth hormone secretagogue receptor 1a (GHS-R1a) in rat osteoblasts using RT-PCR and immunohistochemistry (IHC). The effect of ghrelin on primary osteoblast-like cell proliferation was examined by recording changes in cell number and the level of DNA synthesis. Osteoblast differentiation markers (Runx2, collagen alpha1 type I [COLI], alkaline phosphatase [ALP], osteocalcin [OCN]) were analyzed using quantitative RT-PCR. We also examined calcium accumulation and ALP activity in osteoblast-like cells induced by ghrelin. Finally, to address the in vivo effects of ghrelin on bone metabolism, we examined the BMD of Sprague-Dawley (SD) rats and genetically GH-deficient, spontaneous dwarf rats (SDR). Ghrelin and GHS-R1a were identified in osteoblast-like cells. Ghrelin significantly increased osteoblast-like cell numbers and DNA synthesis in a dose-dependent manner. The proliferative effects of ghrelin were suppressed by [D-Lys(3)]-GHRP-6, an antagonist of GHS-R1a, in a dose-dependent manner. Furthermore, ghrelin increased the expression of osteoblast differentiation markers, ALP activity, and calcium accumulation in the matrix. Finally, ghrelin definitely increased BMD of both SD rats and SDRs. These observations show that ghrelin directly stimulates bone formation.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.